Patent ID: 8575308
Filing Date: 2013-11-05
Classification: A61K,A61P,C07K

Abstract:
1. A method for treating cancer, the method comprising: administering to a subject in need thereof who is positive for HLA-A24 and positive for WT1 protein a therapeutically effective amount of a compound of formula (1) or a pharmaceutically acceptable salt thereof; wherein formula (1) is: wherein X is a tyrosine residue or a methionine residue; each of Y and Z is independently selected from the group consisting of a single bond and a divalent peptide group consisting of 1-10 amino acid residues, R R R R wherein: W is an amino acid residue, m is 1 or 2, and n is an integer of 0-2, with the proviso that when n is 0, then R 3 is hydrogen or alkyl.